Work

Mechanism underlying palmitic acid-driven lipid reprogramming via the PHF2/SREBP1c axis in liver cancer

Year: 2024
Type: dissertation
Abstract: Cancer is a fundamental disorder involving uncontrolled cell growth with the potential for metastasis and invasion. To support their rapid proliferation, cancer cells reprogram lipid metabolism and utilize lipids as building blocks. Among lipids, palmitic acid (PA) is the most common fatty acid found in the human body and mediates post-translational lipid modification named palmitoylation. Although many proteins undergo palmitoylation, their pathophysiological functions in cancer cells are poorly understood. In this dissertation, I discover the molecular mechanisms of palmitoylation-driven lipid reprogramming in liver cancer cells. PA accelerates zinc finger DHHC-type palmitoyltransferase 23 (ZDHHC23)-mediated palmitoylation of a plant homeodomain finger protein 2 (PHF2), resulting in ubiquitin-dependent degradation of PHF2. This dissertation also suggests that PHF2 is an intrinsic tumor suppressor by acting as an E3 ubiquitin ligase of sterol regulatory element binding protein 1c (SREBP1c), a major transcription factor of lipid synthesis in the liver. PHF2 directly binds to SREBP1c and induces degradation of SREBP1c, thereby repressing lipogenesis and proliferation of HCC cells. Notably, PHF2 loss-induced SREBP1c induction increases cellular free fatty acids and consequent PA induction creates the vicious PA/PHF2/SREBP1c cycle. Overall, these findings unravel a previously unexplored lipid reprogramming by a diet rich in PA and excessive PA in cells. Since PA seems to act as a molecular checkpoint of this axis, palmitate intake should be carefully monitored in patients with liver cancer.
Author: 정도원
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7067509488
Cites: 153
Cited by:
Related to: 10